Gabapentin Tablet, Coated
Product Images NDC 83301-0002

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 83301-0002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (600mg 100tablets Updated)

Label for Gabapentin Tablets USP, 600 mg strength, film-coated oral tablets. The label shows a count of 100 tablets and states storage instructions along with pharmacist dispensing guidance. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. and labeled for Mullan Pharmaceutical Inc.*

FDA Label Image

Image Description (600mg 500tablets Updated)

Gabapentin Tablets USP 600 mg, film-coated oral tablets in a package containing 500 tablets. The label includes storage instructions for maintaining the product between 15° to 30°C and dispensing guidance in child-resistant containers. Manufactured for Mullan Pharmaceutical Inc., Pasadena, CA, and by CSPC Ouyi Pharmaceutical Co., Ltd. in China. The label also features barcodes and regulatory information.*

FDA Label Image

Image Description (800mg 100tablets Updated)

Gabapentin Tablets USP 800 mg film-coated oral tablets label showing a 100-tablet package. The label includes dosage strength, storage instructions, dispensing information, barcode, and manufacturer details for CSPC Ouyi Pharmaceutical Co., Ltd., with Mullan Pharmaceutical Inc. as the labeler.*

FDA Label Image

Image Description (800mg 500tablets Updated)

Gabapentin Tablets, USP 800 mg coated tablets label showing packaging for 500 tablets. The label includes dosing and storage instructions, manufacturer Mullan Pharmaceutical Inc., and a barcode. The tablets are oral prescription medication by Mullan Pharmaceutical Inc.*

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure of gabapentin, a human prescription drug. The diagram shows a cyclohexane ring attached to an amino and a carboxyl group, representing the molecular structure of gabapentin.*

FDA Label Image

Figure 1 (Gabapenin 02)

A line graph showing mean pain score over an 8-week period comparing placebo and Gabapentin at 3,600 mg/day. The x-axis represents weeks from baseline through Week 8, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis displays mean pain scores from 0 to 9. Gabapentin shows a decreasing pain score trend, while placebo remains relatively steady.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph depicting mean pain scores over a timeline of 7 weeks. The x-axis represents weeks with a labeled 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Data lines compare placebo, Gabapentin 1,800 mg/day, and Gabapentin 2,400 mg/day, illustrating changes in pain scores during the study periods.*

FDA Label Image

Figure 3 (Gabapenin 04)

Bar graph comparing efficacy results across two separate studies. Study 1 shows 12% for placebo and 29% for Gabapentin 3,600 mg. Study 2 shows 14% for placebo, 32% for Gabapentin 1,800 mg, and 34% for Gabapentin 2,400 mg. Statistical significance markers indicate p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapenin 05)

A scatter plot comparing the percentage difference across three studies (Study a, Study b, Study c) by daily dose of Gabapentin in milligrams, ranging from 600 mg to 1800 mg. The vertical axis shows difference (%) and each study is represented by different symbols and shades (black, gray, white).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.